Concepts (132)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pneumonectomy | 8 | 2026 | 131 | 1.850 |
Why?
|
| Lung Neoplasms | 8 | 2026 | 712 | 1.320 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 4 | 2026 | 186 | 0.820 |
Why?
|
| Quality Assurance, Health Care | 1 | 2026 | 253 | 0.810 |
Why?
|
| Quality Indicators, Health Care | 1 | 2026 | 349 | 0.740 |
Why?
|
| Robotic Surgical Procedures | 3 | 2025 | 172 | 0.500 |
Why?
|
| Neoplasm Staging | 4 | 2026 | 554 | 0.320 |
Why?
|
| Frailty | 2 | 2022 | 132 | 0.300 |
Why?
|
| Esophagectomy | 3 | 2024 | 53 | 0.280 |
Why?
|
| Retrospective Studies | 11 | 2026 | 6957 | 0.280 |
Why?
|
| Mediastinal Neoplasms | 1 | 2006 | 21 | 0.250 |
Why?
|
| Pheochromocytoma | 1 | 2006 | 31 | 0.240 |
Why?
|
| Postoperative Complications | 4 | 2026 | 1336 | 0.240 |
Why?
|
| Operative Time | 1 | 2026 | 94 | 0.230 |
Why?
|
| Operating Rooms | 1 | 2026 | 60 | 0.230 |
Why?
|
| Conversion to Open Surgery | 1 | 2025 | 15 | 0.220 |
Why?
|
| Neoadjuvant Therapy | 1 | 2026 | 102 | 0.220 |
Why?
|
| Thoracic Surgery, Video-Assisted | 1 | 2025 | 62 | 0.220 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2026 | 420 | 0.220 |
Why?
|
| Resuscitation | 1 | 2025 | 67 | 0.220 |
Why?
|
| Thoracic Surgery | 2 | 2025 | 80 | 0.220 |
Why?
|
| Thoracic Surgical Procedures | 1 | 2025 | 42 | 0.210 |
Why?
|
| Time-to-Treatment | 1 | 2026 | 133 | 0.210 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2025 | 128 | 0.210 |
Why?
|
| Databases, Factual | 2 | 2025 | 888 | 0.200 |
Why?
|
| Anastomotic Leak | 1 | 2024 | 36 | 0.200 |
Why?
|
| Esophageal Diseases | 1 | 2023 | 16 | 0.200 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2007 | 466 | 0.200 |
Why?
|
| Humans | 22 | 2026 | 65845 | 0.190 |
Why?
|
| Esophageal Neoplasms | 1 | 2024 | 94 | 0.190 |
Why?
|
| Societies, Medical | 1 | 2025 | 401 | 0.190 |
Why?
|
| Brazil | 1 | 2021 | 104 | 0.170 |
Why?
|
| Male | 14 | 2026 | 31410 | 0.170 |
Why?
|
| Hernia, Hiatal | 1 | 2021 | 29 | 0.170 |
Why?
|
| Robotics | 1 | 2022 | 86 | 0.160 |
Why?
|
| Aged | 12 | 2026 | 15147 | 0.160 |
Why?
|
| Healthcare Disparities | 1 | 2026 | 413 | 0.160 |
Why?
|
| Analgesics, Opioid | 1 | 2025 | 532 | 0.160 |
Why?
|
| Multivariate Analysis | 1 | 2021 | 932 | 0.150 |
Why?
|
| Quality Improvement | 1 | 2024 | 473 | 0.150 |
Why?
|
| Surgical Procedures, Operative | 1 | 2020 | 145 | 0.150 |
Why?
|
| Female | 12 | 2026 | 34425 | 0.140 |
Why?
|
| Early Detection of Cancer | 1 | 2021 | 327 | 0.140 |
Why?
|
| Opioid-Related Disorders | 1 | 2025 | 532 | 0.130 |
Why?
|
| Middle Aged | 9 | 2026 | 18501 | 0.130 |
Why?
|
| Laparoscopy | 1 | 2021 | 492 | 0.120 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2020 | 811 | 0.120 |
Why?
|
| Muscle, Smooth | 2 | 2013 | 135 | 0.110 |
Why?
|
| Bronchodilator Agents | 2 | 2013 | 122 | 0.110 |
Why?
|
| Emergencies | 2 | 2025 | 124 | 0.100 |
Why?
|
| Preoperative Care | 2 | 2020 | 199 | 0.100 |
Why?
|
| Taste | 1 | 2013 | 41 | 0.090 |
Why?
|
| Bronchi | 1 | 2013 | 86 | 0.090 |
Why?
|
| Adenoma | 1 | 2013 | 70 | 0.090 |
Why?
|
| United States | 4 | 2026 | 8189 | 0.080 |
Why?
|
| Lymphatic Metastasis | 2 | 2007 | 94 | 0.080 |
Why?
|
| Mediastinum | 2 | 2007 | 28 | 0.080 |
Why?
|
| Calcium | 2 | 2013 | 587 | 0.080 |
Why?
|
| Ethanolamines | 1 | 2009 | 19 | 0.080 |
Why?
|
| Risk Assessment | 3 | 2024 | 2116 | 0.070 |
Why?
|
| Risk Factors | 3 | 2024 | 5475 | 0.070 |
Why?
|
| Survival Rate | 2 | 2007 | 849 | 0.070 |
Why?
|
| Reoperation | 2 | 2025 | 307 | 0.070 |
Why?
|
| Etoposide | 1 | 2007 | 34 | 0.070 |
Why?
|
| Incidence | 2 | 2021 | 1433 | 0.060 |
Why?
|
| Radiotherapy Dosage | 1 | 2007 | 88 | 0.060 |
Why?
|
| Adult | 6 | 2025 | 17579 | 0.060 |
Why?
|
| Respiration Disorders | 1 | 2007 | 26 | 0.060 |
Why?
|
| Pleural Neoplasms | 1 | 2007 | 19 | 0.060 |
Why?
|
| Disease-Free Survival | 1 | 2007 | 245 | 0.060 |
Why?
|
| Mesothelioma | 1 | 2007 | 28 | 0.060 |
Why?
|
| Cisplatin | 1 | 2007 | 145 | 0.060 |
Why?
|
| Lung Transplantation | 1 | 2006 | 75 | 0.060 |
Why?
|
| Tissue Donors | 1 | 2006 | 147 | 0.060 |
Why?
|
| Cause of Death | 1 | 2006 | 221 | 0.060 |
Why?
|
| Delphi Technique | 1 | 2025 | 113 | 0.050 |
Why?
|
| Propensity Score | 1 | 2025 | 192 | 0.050 |
Why?
|
| Treatment Outcome | 3 | 2025 | 5834 | 0.050 |
Why?
|
| Stomach | 1 | 2024 | 87 | 0.050 |
Why?
|
| Necrosis | 1 | 2023 | 147 | 0.050 |
Why?
|
| Morbidity | 1 | 2022 | 110 | 0.050 |
Why?
|
| Elective Surgical Procedures | 1 | 2022 | 120 | 0.040 |
Why?
|
| Interrupted Time Series Analysis | 1 | 2021 | 31 | 0.040 |
Why?
|
| Delivery of Health Care | 1 | 2026 | 439 | 0.040 |
Why?
|
| Lung | 2 | 2021 | 969 | 0.040 |
Why?
|
| Surgical Mesh | 1 | 2021 | 60 | 0.040 |
Why?
|
| Herniorrhaphy | 1 | 2021 | 72 | 0.040 |
Why?
|
| Logistic Models | 1 | 2024 | 1274 | 0.040 |
Why?
|
| Preoperative Period | 1 | 2020 | 67 | 0.040 |
Why?
|
| Thoracotomy | 2 | 2013 | 47 | 0.040 |
Why?
|
| Recurrence | 1 | 2021 | 665 | 0.040 |
Why?
|
| Patient Care Team | 1 | 2022 | 338 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2021 | 1663 | 0.030 |
Why?
|
| Walking | 1 | 2020 | 248 | 0.030 |
Why?
|
| Medicare | 1 | 2021 | 629 | 0.030 |
Why?
|
| Clinical Competence | 1 | 2022 | 731 | 0.030 |
Why?
|
| Chloroquine | 1 | 2013 | 56 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 2013 | 491 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2013 | 899 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2013 | 993 | 0.020 |
Why?
|
| Oscillometry | 1 | 2009 | 12 | 0.020 |
Why?
|
| Microscopy, Phase-Contrast | 1 | 2009 | 15 | 0.020 |
Why?
|
| Histamine | 1 | 2009 | 21 | 0.020 |
Why?
|
| Inositol 1,4,5-Trisphosphate | 1 | 2009 | 27 | 0.020 |
Why?
|
| Formoterol Fumarate | 1 | 2009 | 21 | 0.020 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2009 | 45 | 0.020 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2009 | 66 | 0.020 |
Why?
|
| Biomarkers, Tumor | 1 | 2013 | 527 | 0.020 |
Why?
|
| Muscle Contraction | 1 | 2009 | 209 | 0.020 |
Why?
|
| Calcium Signaling | 1 | 2009 | 168 | 0.020 |
Why?
|
| Mediastinoscopy | 1 | 2007 | 8 | 0.020 |
Why?
|
| Donor Selection | 1 | 2006 | 15 | 0.020 |
Why?
|
| Prosthesis Implantation | 1 | 2007 | 30 | 0.020 |
Why?
|
| Syndrome | 1 | 2007 | 182 | 0.020 |
Why?
|
| Bronchoscopy | 1 | 2007 | 88 | 0.020 |
Why?
|
| Probability | 1 | 2006 | 170 | 0.020 |
Why?
|
| Radiography, Thoracic | 1 | 2007 | 117 | 0.010 |
Why?
|
| Graft Survival | 1 | 2006 | 300 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2013 | 3506 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2006 | 579 | 0.010 |
Why?
|
| Graft Rejection | 1 | 2006 | 304 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2007 | 378 | 0.010 |
Why?
|
| Patient Selection | 1 | 2007 | 484 | 0.010 |
Why?
|
| Animals | 2 | 2013 | 21493 | 0.010 |
Why?
|
| Age Factors | 1 | 2006 | 1595 | 0.010 |
Why?
|
| Young Adult | 1 | 2013 | 4883 | 0.010 |
Why?
|
| Prognosis | 1 | 2007 | 1793 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2006 | 2500 | 0.010 |
Why?
|
| Time Factors | 1 | 2006 | 3779 | 0.010 |
Why?
|
| Mice | 1 | 2013 | 11185 | 0.010 |
Why?
|
| Child | 1 | 2006 | 4653 | 0.010 |
Why?
|
| Adolescent | 1 | 2006 | 6368 | 0.010 |
Why?
|